NOMAD Power Solutions, Inc. (NMAD)
NMAD Stock Price Chart
Explore NOMAD Power Solutions, Inc. interactive price chart. Choose custom timeframes to analyze NMAD price movements and trends.
NMAD Company Profile
Discover essential business fundamentals and corporate details for NOMAD Power Solutions, Inc. (NMAD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Nov 2020
Employees
3.00
Website
http://www.lixte.comCEO
Geordan G. Pursglove
Description
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.
NMAD Financial Timeline
Browse a chronological timeline of NOMAD Power Solutions, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 May 2026
NMAD Stock Performance
Access detailed NMAD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
